Hypericum perforatom (St John's wort) in depression: Pest or blessing?

Medical Journal of Australia

Volumn 169, Issue 11-12, 1998, Pages 583-586

  Rey, Joseph M ^a,b   Walter, Garry ^a,b  

^a Rivendell Child & Adolescent Unit   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; HYPERICUM PERFORATUM EXTRACT; MONOAMINE OXIDASE INHIBITOR;

ARTICLE; BOTANY; CLINICAL RESEARCH; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG QUALITY; DRUG SAFETY; DYSPNEA; EMOTIONALITY; ETHICS; FATIGUE; FLUSHING; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART PALPITATION; HUMAN; HYPERESTHESIA; HYPERVENTILATION; META ANALYSIS; MYDRIASIS; NAUSEA; PAIN; PHOTOSENSITIVITY; PRESCRIPTION; PRURITUS; QUALITY CONTROL; RESTLESSNESS; RHINITIS; TREMOR; VERTIGO; WEIGHT GAIN; ADULT; ALTERNATIVE MEDICINE; ANGIOSPERM; AUSTRALIA; COMPARATIVE STUDY; PHYTOTHERAPY; REVIEW;

ADULT; ANTIDEPRESSIVE AGENTS; AUSTRALIA; COMPLEMENTARY THERAPIES; DEPRESSIVE DISORDER; HUMANS; PHYTOTHERAPY; THEALES;

EID: 0032556549     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1998.tb123424.x     Document Type: Article

References (22)

1. MacLennan AH, Wilson DH, Taylor AW. Prevalence and cost of alternative medicine in Australia. Lancet 1996; 347: 569-573.
2. Kristoffersen SS, Atkin PA, Shenfield GM. Uptake of alternative medicine [letter]. Lancet 1996; 347: 972.
3. Thompson A. As patients embrace herbal remedies, dearth of scientific evidence frustrates clinicians. Am J Health Syst Pharm 1997; 54: 2656, 2658, 2664.
4. Chavez ML, Chavez ML. Saint John's wort. Hosp Pharm 1997; 32: 1621-1632.
5. Linde K, Ramirez G, Mulrow CD, et al. St. John's wort for depression: an overview and meta-analysis of randomised clinical trials. BMJ 1996; 313: 253-258.
6. Cass H. St John's wort: nature's blues buster. New York: Avery Publishing Group, 1998.
7. Zuess J. The natural Prozac program: how to use St John's wort, the antide pressant herb. New York: Three Rivers Press, 1997.
8. Wohlmuth H. St John's wort - phylotherapy for depression. Botanical Pathways 1997; 2: 3-5.
9. Nash M. Nature's Prozac? Time 1997; Sep 22: 80-81.
10. De Smet PAG, Nolen WA. St John's wort as an antidepressant. BMJ 1996; 313: 241-242.
11. Parsons WT. Noxious weeds of Victoria. Melbourne, Inkata Press, 1973.
12. Crossweller A. Farmers to cash in by weeding out wort. Daily Telegraph (Sydney). 1998; July 6: 5.
13. Steger W. Depressive verstimmungen. Z Allgemeinmed 1985; 61: 914-918.
14. Werth W. Psychotonin M versus imipramin in der chirurgie. Der Kassenarzt 1989; 15: 64-68.
15. Vorbach EU, Hubner WD, Arnoldt KH. Effectiveness and tolerance of the hypericum extract L1 160 in comparison with imipramine: randomised double blind study with 135 outpatients. J Geriatr Psychiatry Neurol 1994; 7 Suppl 1: S19-S23.
16. Kniebel R, Burchard JM. Zur therapie depressive verstimmungen in der praxis. Z. Allgemeinmed 1988; 64: 689-696.
17. Bergmann R, Nubner J, Demling J. Behandlungen leichter bis mittelschwerer depressionen. Therapiewoche Neurologie/Psychiatrie 1993; 7: 235-240.
18. Warnecke G. Beeinflussung klimakterischer depressionen. Z Allgemeinmed 1986; 62: 1111-1113.
19. Panijel J. Die behandlung mittelschwerer angstustande. Therapiewoche 1985; 41: 4659-4668.
20. Harrer G, Hubner WD, Podzuweit H. Effectiveness and tolerance of the hypericum extract L1 160 compared with maprotiline: a multi-centre double-blind study. J Geriatr Psychiatry Neurol 1994; 7 Suppl 1: S24-S28.
21. Ditzler K, Gessner B, Schatton WFH, Willems M. Clinical trial on Neuropas versus placebo in patients with mild to moderate depressive symptoms: a placebo-controlled, randomised double-blind study. Complement Ther Med 1994; 2: 5-13.
22. World Health Organization. The ICD-10 classification of mental and behavioral disorders. Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization, 1992; 121-122.